Search results
Stéphane Bancel (born 20 July 1972) [1] is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
Aug 27, 2021 · Bancel spoke with McKinsey’s Olivier Leclerc about why he believes his company was well positioned to respond to the COVID-19 crisis, how scientific breakthroughs with mRNA led to an effective COVID-19 vaccine, and what it takes to lead his company for long-term impact during the crisis.
People also ask
Who is Stéphane Bancel?
How much did Moderna CEO Stéphane Bancel earn last year?
How does Bancel make money?
How much are Bancel's stock options worth?
Mar 28, 2021 · In this episode, a16z's Jorge Conde and Hanne Winarsky spoke with Stéphane Bancel, CEO of Moderna. Bancel shares how his company used the mRNA platform to develop and create the COVID-19 vaccine...
Apr 26, 2023 · Moderna’s CEO shares what it was like to leap from pre-revenue startup to household name and Fortune 500 company. BY Fortune Editors. April 26, 2023, 4:00 PM PDT. Modern CEO Stephane Bancel ...
Nov 2, 2023 · We expect to return to sales growth in 2025 and, through disciplined investment, to break even in 2026," said CEO Stéphane Bancel. For Q3, the company reported a $3.6 billion net loss,...
Mar 29, 2022 · Two years later, thanks in no small part to the efforts of French-born CEO Stéphane Bancel, the company’s COVID-19 vaccine has saved an untold number of lives across the world, with trials ...
Apr 29, 2023 · 7 min. Stéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that netted him nearly $393 million. The company decided his pay wasn’t good enough.
